Back to search results
NCT06041581

SHADES Mechanistic Trial

Enrolling by Invitation
NAAges 40+InterventionalPrevention
Indiana University
~200 participants
Updated 2025-07-14 on ClinicalTrials.gov
What's tested:Sleep Healthy Using The Internet (SHUTi)Telephonic CBT-IFace-to-Face CBT-IActive Control: Sleep Education/Hygiene, Symptom Monitoring, and Usual Primary Care

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
High-Sensitivity C-Reactive Protein (hsCRP)
Measured over Baseline, 6 months

Conditions

Insomnia
Insomnia Chronic
Insomnia, Primary
Sleep Disturbance
Sleep Disorder
Cardiovascular Diseases
Heart Diseases
Coronary Artery Disease
Stroke
Autonomic Dysfunction
Systemic Inflammatory Response
Metabolic Disease

Explore related trials

Insomnia

Where it's being run

1 sites across 1 states
Indiana1

Study leadership

  • Jesse C Stewart, Ph.D. · PRINCIPAL_INVESTIGATOR · Indiana University

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

What this trial measures

  • High-Sensitivity C-Reactive Protein (hsCRP)Baseline, 6 months

    The primary outcome is 6-month change in hsCRP assessed by the Human CRP Quantikine ELISA (R\&D Systems). hsCRP is a circulating inflammation biomarker that is implicated in the pathophysiology of CVD and is a predictor of future CVD events.